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REPOSITORY PENICILLIN THERAPY OF PINTA
IN THE MEXICAN PEASANT
A CLINICAL AND SEROLOGIC SURVEY
CHARLES H. REIN, M.D.,* DELMAS K. KITCHEN, M.D.,* FRANCISCO MARQUEZ,
M.D.f AND GERARDO VARELA, M.D4
Pinta, or mal del pinto, is a non-venereal treponematosis known by many col-
loquial names. It is an ancient primitive tropical disease essentially in the
Western Hemisphere which probably existed among the Aztecs at the time of the
Spanish Conquest. Iriate (1) believes that at least 400,000 cases are present in
Colombia. The Mexican Public Health Department Census (2) in 1929—1931, re-
vealed a prevalence of more than 250,000 cases in Mexico with a predominance in
the southern and southwestern areas. It is estimated that the prevalence has
increased to more than one-half million patients with this disease in Mexico.
The disease also occurs in Cuba, Haiti, Dominican Republic, Ecuador, Argen-
tina, Venezuela, Peru and Central America.
The incidence rate for all of Mexico (2) is 1.61 per cent, but according to the
population of each state the prevalence is as follows: Guerrero 20.51 per cent,
Oaxaca 3.98 per cent, Mexico 3.36 per cent, Chiapas 2.95 per cent, Michoacan
2.43 per cent, Puebla 1.91 per cent, Tabasco 1.71 per cent, Morelos 1.01 per cent,
Nayarit 0.06 per cent, Veracruz 0.023 per cent, Colima 0.02 1 per cent, and Jalisco
0.0015 per cent.
The present report deals with the evaluation of the clinical and serologic results
in a series of 665 Mexican Indian peasants with pinta. They were treated with
microcrystalline procaine penicillin G gelled in oil and aluminum monostearate
(PAM). § The study was started on September 8, 1948.
The age distribution was as follows:
Age Paltmls Per ce,
1—5 60 9.02
6—10 143 21.50
11—15 134 20.15
16—20 115 17.29
21—30 141 21.20
31—40 47 7.07
41—50 17 2.55
51 or more 8 1.20
Total 665
* From the Department of Dermatology and Syphilology of the New York University-
Post Graduate Medical School (Dr. Marion B. Sulzherger, Chairman) and the Skin and Can-
cer Unit of the New York University Hospital.
t From the Central Military Hospital of the Army Health Department of Mexico.
t From the Institute of Health and Tropical Diseases, Mexico.
Read before the 12th Annual Meeting of the Society for Investigative Dermatology,
Atlantic City, New Jersey, June 7—8, 1951.
§ "lFloeillin-96" was supplied in 10 cc. vials, containing 300,000 units per cc. This project
was made possible by the sponsorship of Bristol Laboratories Inc., Syracuse, New York.
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It will be noted that pinta is essentially a disease of childhood since it is con-
tracted by casual contact early in life. Although there is no evidence for the
existence of congenital pinta, over 41 per cent of all patients in onr series were in
the age group of from five to 15 years.
Clinical manifestations are, so far as we know, confined entirely to the skin.
There is no proven evidence that there ever occurs visceral or central nervous
system involvement. The lesions are so varied and intermingled that classifica-
tion into sharply delineated stages, as in the case of the other treponemal diseases,
is almost impossible.
The eases were classified into early and late stages and the following is a brief clinical
description of our patients in each.
A. Early Pinto
1. Primary stage. The first manifestation of the disease is the initial lesion which develops
at the site of inoculation. As has been shown experimentally by Latapi and Leon y Blanco
(3, 4), the lesion appears approximately seven to 10 days after inoculation. Oteiza (5) in his
experimental inoculations in mau has shown prolonged incubation periods, up to 61 days.
The above-mentioned authors describe the primary lesion as beginning as a small lentic-
ular papule which soon becomes scaly and erythematous. It progresses slowly and after
two or three months it is only two to three centimeters in diameter. The lesion increases
in size by peripheral extension or by coalescence with satellite papules that later develop
around it (6).
In our experience with the naturally acquired infection, the development of the primary
lesion is similar. We have observed that primary lesions of approximately 15 to 30 days'
duration appear as small, lenticular, slightly scaly papules approximately one centimeter in
diameter. In about one to two months these lesions reach a diameter of two to three centi-
meters and the morphology changes, the lesions becoming circinate and also psoriasiform,
particularly in the older lesions. The circinate lesions are slightly scaly and erythematous,
with an annular outline and with a slightly elevated border. The psoriasiform plaque is a
scaly, red-salmon or reddish-white, sharply marginated lesion. In both types the primary
lesions continue to increase slowly in size and may reach a diameter of 10 centimeters or
more in about one to two years. Frequently, the primary lesion becomes surrounded by
satellite lesions which may fuse with it and form together a larger configurate pattern.
The distribution of the primary lesions in our patients was as follows:
No,nber of Location of
Patients Lesiono
8 lower extremitics
5 neck
3 face
3 upper extremities
3 chest
2 loin
1 abdomen
Total 25
Lesions of the lower extremities appeared on the dorsum of the feet and the ankles. Lesions
frequently occurred on the buttocks. Lesions of the upper extremities appeared on the wrists
and forearms. Lesions of the face occurred on the chin and cheeks. Primary lesions of the
genitalia were not observed.
2. Secondary stage. Secondary lesions appear from one month to one year or more follow-
ing the infection. Sometimes they are scarce, only two or three occurring, but they may be
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more numerous. Extensive dissemination, as in syphilis, was a rare occurrence in most of our
cases. Primary and secondary lesions may appear identical, being psoriasiforni or circinate.
Occasionally the secondary lesions may become pustular and crusted. In analogy to syphilis,
Latapi and Leon y Blanco suggested the term "pintides" for this secondary, disseminated
stage. Pintides may appear on the same sites as the primary lesions. In our experience the
scalp, axillae, groins and genitalia were not involved.
Initially, pintides are erythematous, but after two or three weeks they become scaly.
Later they become centrally pigmented, first appearing copper colored and after some time,
slate-blue. Although some lesions undergo pigmentation after several months, others change
color during the first month. In from three months to one year some of the pintides show
gradations of depigmentation, some completely and others either peripherally or in small
areas. Often pintides have a mottled appearance caused by alternating patches of erythema,
pigmentation and leukoderma. Finally, the regressing pintides may become completely
depigmented. Although this achromia occurs most frequently ix months to one year after
the appearance of the pintides, it may occur earlier. We have seen leukoderma develop in
some patients within three months after the appearance of the secondary lesion (early leuko.
derma). Pintides may recur early (two to three years), or late (10 to 15 years). Recurrent
pintides may appear on the same sites as the early manifestations, but are less numerous
and frequently larger, havirig a diameter of 20 centimeters or more. Although psoriasiform
and occasionally circinate, they may appear as erythematous, scaly plaques with ill-defined
borders. This type frequently becomes kerato tic, especially when located on the legs, knees,
ankles, wrists, elbows and loin. In some instances, new recurrent erythematous plaques may
intermingle with the areas of leucoderma resulting from the original pintides. It is difficult
to classify such patients since they have secondary and late pinta lesions at the same time
(intermediate type). Recurrent pintides undergo the same regressive changes as noted in
the original disseminated lesions.
B. Late Pinta
Leukoderma or "white pinta," as it has been frequently called, represents the terminal
stage of the disease. Classification, however, of this stage is also extremely difficult since it
does not necessarily reflect the duration of the disease, but rather the rate of regression to
the achromic phase. This may occur as early as three months following the onset, yet we
have observed many patients with this achromia in whom there also existed concomitant
recurrent pintides for many years. Therefore, some patients may present the late stage or
achromic lesions in a few months, while other patients may continue to develop recurrent
secondary lesions for many years.
The late changes proceed in an irregular fashion allowing an intermingling of all varieties
of dyschromia, hypochromia and achromia. Patients presenting concomitant secondary
lesions and leukodermic patches (intermediate type) were classified in the late stage. In
some areas, chiefly over bony prominences, the areas of leukoderma tend to enlarge by pe-
ripheral extension.
INVESTIGATIONAL DESIGN AND RESULTS
As part of our investigation, the treponemal disappearance time was deter-
mined following the administration of PAM. Single injections of 300,000 units
and 1,200,000 units resulted in an average identical disappearance tine of six to
10 hours in both instances. Preliminary investigations of the disappearance time
following the administration of aureomycin, streptomycin and chloromycetin
indicate a lessened efficacy as judged by a much longer time required for dis-
appearance.
The following schedules of therapy were used:
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Schedule A: A single injection of 4 cc. (1,200,000 units). Three-hundred-ninety-
two patients were treated of which 214 were available for re-examination.
Schedule B: One injection of 1 cc. (300,000 units) at daily intervals for four
days (1,200,000 units). Eleven patients were treated of which six were available
for re-examination.
Schedule C: One injection of 4 cc. (1,200,000 units) at weekly intervals for four
weeks (4,800,000 units). Twenty-nine patients were treated of which 12 were
available for re-examination.
Schedule D: One injection of 1 cc. (300,000 units) at weekly intervals for four
weeks (1,200,000 units). Two-hundred-thirty-three patients were treated of
which 118 were available for re-examination.
All patients, regardless of age or weight, received the same amount of therapy
in their respective groups. Prior to the institution of therapy a blood specimen
was collected and each was subjected to a battery of three quantitative tests in-
cluding the Kahn standard, the Marquez-Rein-Hazay and the Rein-Bossak
flocculation procedures. The latter test employed a cardiolipin-lecithin-cholesterol
antigen. Following therapy, the patients were subjected to clinical and serologic
examinations at varying intervals up to two years. This proved to be the most
difficult part of the experiment. Pinta is most prevalent in the rural areas, and
in order to reach the treatment center, the patients are obliged to travel on foot
for many miles over mountains and bad roads, which often are completely flooded
during the rainy season. After the clinical aspects of the disease have disappeared,
the patient is not impressed with the necessity for returning and therefore, it
became necessary to seek the treated individuals, at great effort, for clinical and
serologic examination.
In order to evaluate the serologic results obtained in these cases, the following
arbitrary criteria and definitions were accepted:
Serologic Cure: This denoted seronegativity attained and maintained following
treatment.
Serologic Improvement: This constituted a reduction in serologic titer, indicating
a satisfactory serologic response, but seronegativity not attained at the time of
the last examination.
Serologic Fastness: This indicated failure to show a reduction in serologic titer
below the pretreatment level.
Serologic Relapse: This constituted an initial reduction in serologic titer fol-
lowed by a sudden and progressive increase in titer, indicating an unsatisfactory
response to penicillin therapy, or an asymptomatic reinfection.
In this report the serologic results are limited to those obtained with the Kahn
standard and quantitative tests, since the majority of publications pertaining to
treatment of pinta employed these procedures. It should be emphasized that the
evaluation of our results would be different had they been based on reactions
with more sensitive tests. The serologic pattern and the degree of serologic im-
provement evidenced by the reactions to the various tests were similar with all
three procedures.
Table I presents data showing the total number of patients initially treated
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with each schedule and the number in each group re-examined following a
period of at least one year.
Table II records numerical data showing the number of patients in each of the
four groups who were serologically cured, improved, fast or relapsed at the end
of this investigation. By our previous definition of serologic cure and serologic
improvement, it will be seen in Schedules A and D respectively, that 73.82 per
cent and 72.89 per cent showed a satisfactory serologic response to shortened
courses of ambulatory penicillin therapy. It is to be expected that there will be
more "serologic cures" during the third year of serologic re-examinations.
TABLE I
Number of patients treated and percentage available for re-examination
SCifEDULE TR.EATED POLLowRD % POLLOWED
A
B
C
D
Total
392
11
29
233
214
6
12
118
54.6
54.5
41.4
50.6
665 350 52.6
TABLE II
SCHEDULES' SEROLOGIC CURE SEROLOGIC IMPRO YE- SEROLOGIC PASIWESS SEROLOGIC RELAPSE
A (214)t
B (6)
C (12)
D (118)t
42 (19.62%)
1 (16.66%)
4 (33.33%)
23 (19.50%)
116 (54.20%)
1 (16.66%)
2 (16.66%)
63 (53.39%)
55 (25.70%)
4 (66.66%)
4 (33.33%)
31 (26.27%)
1 (0.46%)
0
2 (16.66%)
1 (0.84%)
* 350 total.
f Serologic cure and serologic improvement: A, 73.82%; D, 72.89%.
Although the serologic response was much slower than in our patients with
syphilis (7, 8), and somewhat slower than our patients with yaws (9), (both
treated similarly or identically), our results were far better than those reported
by other investigators following heavy metal therapy (10). The slowness of sero-
logic response is probably a direct reflection of the duration of the disease. A
large number of our patients with pinta had the disease for many years prior to
treatment.
Clinically, the results were not as rapid as those obtained with penicillin ther-
apy in yaws or syphilis. It was our experience in patients with yaws that the
primary and secondary lesions were in the desiccation stage in four days, at
which time the crusts could be easily removed, revealing a dry and well-healed
underlying skin. Complete healing of all lesions was observed in most instances
on the first re-examination three months following completion of therapy. In
pinta, however, four to six months elapsed before the primary or early secondary
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lesions (erythematous pintides) disappeared. These lesions healed without any
scars or achromic residuum. In no patient has there been any evidence of clinical
relapse or reinfection to date.
The late secondary pintides include the recurrent erythematous lesions as well
as the slate-pigmented and hypochromic lesions. These required from six to 12
months for complete healing, but the former lesions disappeared without any
residual scars while the latter usually left a leucodermic patch at the site of the
original lesion.
Of special interest were the results noted in the leukodermic lesions. In patients
with areas of leukoderma of short duration there was a complete reappearance
TABLE III
Clinical results with Schedule A
(One single injection of 1,200,000 units)
PRIMARY (6) SECONDARY (87) LATE (121)
Cured 6 (100%) 62 (71.2%)
Improved 25 (28.8%)
No change
47 (38.8%)
61 (50.4%)
13 (10.8%)
* Includes 79 patients of the intermediate type.
TABLE IV
Clinical results with Schedule B
(Four daily injections of 300,000 units; total, 1,200,000
PRIMARY (0) SECONDARY (1)
units)
LATE (5)
Cured 1 (100%)
Improved
No change
5 (100%)
* All intermediate type.
of normal pigment except when they were located over bony prominences (el-
bows, knuckles, wrists and ankles). In theseareas there was a spotty recurrence
of pigment or the patches of leukoderma were reduced in size. In patients with
leukoderma of long duration there was rarely a recurrence of pigmentation.
Tables III to VII inclusive, present data concerned with the clinical results
at the time of this report. Tho high cure and improvement rate and the low per-
centage of patients presenting no change clinically, is characteristic of the clin-
ical response to peniciffin. "Clinical cure" is used to indicate that the active
cutaneous lesions have disappeared. In some patients with late pinta, the patches
of leukoderma of long duration may persist after all active cutaneous lesions
have disappeared and seronegativity has been attained and maintained. Such
leukodermic areas must be considered as residual scars of the disease. The per-
sistence of leukodermic scars does not necessarily indicate a persistence of ac-
tivity. It is the opinion of one of us (G. V.) that the clinical response to peni-
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cillin therapy alone is more rapid and satisfactory than with the previously em-
ployed heavy metals and the more recently employed aureomycin, chloromycetin
and streptomycin.
In Table VII it will be noted that all patients with primary lesions attained
and maintained clinical cures. In patients with early pintides, 68.9 per cent had
attained and maintained a clinical cure, while the remaining 31.1 per cent had
TABLE V
Clinical results with Schedule C
(Four weekly injections of 1,200,000 units; total, 4,800,000 units)
PRIMARY (4) SECONDARY (8) LATE (0)
Cured
Improved
No change
4 (100%) 6 (80%)
2 (20%)
TABLE VI
Clinical results with Schedule D
(Four weekly injections of 300,000 units; Total, 1,200,000 units)
PRIKARY (6) SECONDARY (55) LATE (57)
Cured
Improved
No change
6 (100%) 35 (63.6%)
20 (36.4%)
22 (38.6%)
30 (52.6%)
5 (8.8%)
* Includes 13 patients of the intermediate type.
TABLE Vu
Combined clinical results in all four schedules of therapy
PRIMARY (16) SECONDARY (151) LATE (183)
Cured
Improved
No change
16 (100%) 104 (68.9%) 74 (40.4%)
47 (31.1%) 91 (49.7%)
18 (9.9%)
There were no proven instances of either clinical relapse or clinical reinfection in these
patients followed from one to two years.
* Includes 97 patients of the intermediate type.
shown a marked clinical improvement at the time of their last examination. Only
18 patients (9.9%) with late pinta, followed for more than one year, failed to
show any appreciable clinical response. Included in the "late group" are 97 pa-
tients of the intermediate type. The results with a single injection of 4 cc. (1,200,-
000 units) appeared somewhat better than an injection of 1 cc. once weekly for
four weeks, even though the total dosage (1,200,000 uthts) was identical in both
treatment schedules. The number of patients treated with Schedules B and C
was too small for statistical significance.
144 TIlE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Of additional interest was the observation that in this group of 350 patients,
80 presented patches of leukoderma in which there was reappearance of normal
pigment.
DISCUSSION
Penicillin in an absorption-delaying menstruum is of utmost value in coun-
tries such as Mexico and Colombia where the majority of patients must be
treated in the shortest period of time and on an ambulatory basis in rural clinics.
The ideal form of therapy appears to be with a single injection of penicillin. In
this manner 100 per cent of those reporting for treatment would receive and
complete therapy in a "single treatment." This is now possible with micro-
crystaffine procaine penicillin G gelled in oil and aluminum monostearate. Our
investigations with this preparation in early syphilis at the New York University-
Bellevue Medical Center indicate that one single injection of 4 to 8 cc. is effective
in more than 90 per cent of patients treated.
From these data it is evident that the clinical response of pinta to a single
treatment schedule is excellent. An absolute minimum dose of 4 cc. (1,200,000
units) is recommended.
CONCLUSIONS
Based on clinical response, repository penicillin (microcrystalline procaine
peniciffin G gelled in oil and aluminum monostearate) is the drug of choice in the
present-day treatment of pinta. This report is based on 665 patients with pinta
treated with four schedules of penicillin therapy. Blood specimens were col-
lected from each patient for serologic examinations prior to treatment. Three-
hundred-fifty patients were available for clinical and serologic re-examination at
varying intervals up to two years following completion of therapy. The clinical
results with penicillin therapy were exceptionally good and far superior to any
other form of therapy ever employed, including heavy metals, aureomycin,
chloromycetin and streptomycin. Serologic results are also presented.
The cause of pinta is known and an effective, ambulatory, single-injection
schedule has been established. Eradication of this disfiguring and stigmatizing
disease now looms as a distinct possibility.
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